Cas No. 1155846-86-8, Benzonitrile, 3-chloro-5-[[1,2-dihydro-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]-

With its powerful efficacy and favorable tolerability, Doravirine empowers patients with a simplified and effective treatment option. As a non-nucleoside reverse transcriptase inhibitor (NNRTI), Doravirine offers exceptional virologic suppression and resistance resistance against common HIV strains. By incorporating Doravirine into your pharmaceutical portfolio, you can enhance patient care, expand treatment options, and make a significant impact on combating the global HIV epidemic. Stay at the forefront of innovation with Doravirine to transform the lives of those living with HIV.

To align with green chemistry, we have implemented the flow chemistry.